On what grounds? The legal force of Advance Healthcare Directives for mental health treatment during involuntary admissions under the Mental Health Act, 2001: A retrospective observational study
Irish Journal of Psychological Medicine · 2026
DOI: 10.1017/ipm.2026.10173 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Irish Journal of Psychological Medicine, 2026. Verfasst von Elaine Joy und 2 weiteren Autor:innen. Beteiligte Einrichtung: St Vincent's University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Advance Directives, Commitment of Persons with Psychiatric Disorders, Mental Disorders, Involuntary Commitment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The intersection between the Assisted Decision-making (Capacity) Act 2022 (ADMCA) and the Mental Health Act, 2001 (MHA) has prompted considerable debate. Although not alone in its differential treatment of mental health and physical health advance healthcare directives (AHDs), Ireland is unique in affording legally binding status to mental health AHDs for some but not all inpatient service users detained under mental health legislation. As such, in this study we aim to compare groups of service users for which AHDs would be binding or not at point of detention and to track changes in binding status over the course of admission.
Methods
This is a retrospective observational study examining involuntary admissions to a 36 bedded acute psychiatric unit in Dublin from 2021 to 2023. Admissions were grouped into those initially detained on grounds of risk or on the treatment criterion alone, as this would determine binding status of a mental health AHD. We also examined changes to binding status over the course of admission to calculate median bed days when a service user would be entitled to a binding AHD. Descriptive statistics and inferential testing (Chi-squared and Mann–Whitney U ) were used to analyse the data.
Results
Of 287 admissions of 212 service users, 73.9% admissions were under the treatment criterion alone and would therefore qualify for a binding AHD. We found that diagnosis, mode of detention, and service division were significantly associated with AHD binding status. Service users would qualify for binding AHDs on 83.6% of involuntary bed days and, of those admissions affirmed by the first tribunal, 89.9% would qualify for binding AHDs in the days afterward.
Conclusion
Most involuntary service users would qualify for a legally binding AHD under the ADMCA for at least part of their admission. Should AHDs become common practice, binding AHDs will play a significant role in inpatient psychiatric care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St Vincent's University Hospital, Dublin, Ireland.
- Liaison Psychiatry, Beaumont Hospital, Dublin, Ireland.
- Department of Psychiatry, University College Dublin, Dublin, Ireland.
ORCID-Profile: Cornelia Carey
Zitieren
APA
Joy, E., Carey, C., & Kane, N. B. (2026). On what grounds? The legal force of Advance Healthcare Directives for mental health treatment during involuntary admissions under the Mental Health Act, 2001: A retrospective observational study. Irish Journal of Psychological Medicine. https://doi.org/10.1017/ipm.2026.10173
Vancouver
Joy E, Carey C, Kane NB. On what grounds? The legal force of Advance Healthcare Directives for mental health treatment during involuntary admissions under the Mental Health Act, 2001: A retrospective observational study. Irish Journal of Psychological Medicine. 2026. doi:10.1017/ipm.2026.10173
BibTeX
@article{Joy2026,
author = {Joy, Elaine and Carey, Cornelia and Kane, Nuala B},
title = {On what grounds? The legal force of Advance Healthcare Directives for mental health treatment during involuntary admissions under the Mental Health Act, 2001: A retrospective observational study},
journal = {Irish Journal of Psychological Medicine},
year = {2026},
doi = {10.1017/ipm.2026.10173}
}
EUVIMED